Form 4 for CELU Celularity Inc
Accepted 2022-07-15 00:00:00 ET · period of report 2022-07-13 · accession 0000899243-22-026188 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-15 | 2022-07-13 | CELU | Fletcher Kyle | GC | A - Grant | $0.00 | +2,297 | 35.4K | +7% | $0 |
| DM | 2022-07-15 | 2022-07-13 | CELU | Fletcher Kyle | GC | A - Grant | $0.00 | +131.7K | 125.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-07-13 | A | A | 2,297 | $0.00 | 35,432 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-07-13 | A | A | 6,735 | $0.00 | 6,735 | D | $10.16 · — to 2032-07-13 | 6,735 Class A Common Stock | (F2) This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-07-13 | A | A | 125,000 | $0.00 | 125,000 | D | $4.15 · — to 2032-07-13 | 125,000 Class A Common Stock | (F3) This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. |